125 related articles for article (PubMed ID: 18516421)
1. [Inactive Graves' ophthalmopathy and self-esteem].
Magalhães CH; Pereira MD; Manso PG; Veiga DF; Novo NF; Ferreira LM
Arq Bras Oftalmol; 2008; 71(2):215-20. PubMed ID: 18516421
[TBL] [Abstract][Full Text] [Related]
2. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
[TBL] [Abstract][Full Text] [Related]
3. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
[TBL] [Abstract][Full Text] [Related]
5. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
6. The relationship between quality of life, cognition, and thyroid status in Graves' disease.
Riguetto CM; Neto AM; Tambascia MA; Zantut-Wittmann DE
Endocrine; 2019 Jan; 63(1):87-93. PubMed ID: 30173328
[TBL] [Abstract][Full Text] [Related]
7. Studies on the occurrence of ophthalmopathy in Graves' disease.
Marcocci C; Bartalena L; Bogazzi F; Panicucci M; Pinchera A
Acta Endocrinol (Copenh); 1989 Apr; 120(4):473-8. PubMed ID: 2718699
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
9. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
[TBL] [Abstract][Full Text] [Related]
10. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
11. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.
Lee H; Roh HS; Yoon JS; Lee SY
Korean J Ophthalmol; 2010 Apr; 24(2):65-72. PubMed ID: 20379454
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Graves' disease and the course of ophthalmopathy.
Sridama V; DeGroot LJ
Am J Med; 1989 Jul; 87(1):70-3. PubMed ID: 2741983
[TBL] [Abstract][Full Text] [Related]
13. Chronology of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
[TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography Thickness Measurements of the Extraocular Rectus Muscle Tendons in Graves' Ophthalmopathy.
De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Ventura-Abreu N; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
J Pediatr Ophthalmol Strabismus; 2018 Nov; 55(6):356-362. PubMed ID: 30160297
[TBL] [Abstract][Full Text] [Related]
15. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
Liao ZQ
Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571
[TBL] [Abstract][Full Text] [Related]
16. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria for Graves' ophthalmopathy.
Bartley GB; Gorman CA
Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696
[TBL] [Abstract][Full Text] [Related]
18. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
[TBL] [Abstract][Full Text] [Related]
19. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
[TBL] [Abstract][Full Text] [Related]
20. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
